Advisory Alpha’s iShares Biotechnology ETF IBB Stock Holding History

Advisory Alpha’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,755	Closed	-$573K	–	280
2021 Q4	$573K	Buy	+3,755	New	+$581K	0.03%	166
2020 Q4	–	Sell	-40	Closed	-$6K	–	334
2020 Q3	$6K	Buy	+40	New	+$5.43K	﹤0.01%	492
2020 Q2	–	Sell	-565	Closed	-$69.6K	–	318
2020 Q1	$69.6K	Sell	565 -50	-8%	-$5.76K	0.02%	177
2019 Q4	$73.3K	Buy	615 +50	+9%	+$5.58K	0.02%	233
2019 Q3	$55.2K	Buy	+565	New	+$59.1K	0.02%	230
2019 Q2	–	Sell	-525	Closed	-$55.3K	–	351
2019 Q1	$55.3K	Buy	+525	New	+$57.6K	0.02%	220

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Advisory Alpha's IBB Position: Q1 2022 in Review

Advisory Alpha sold out of iShares Biotechnology ETF (IBB) in Q1 2022, closing a stake of 3,755 shares — an estimated $573K sold.

Advisory Alpha first reported a position in IBB in Q1 2019 and held it in 6 quarters. The position peaked at $573K in Q4 2021. 897 funds tracked by Wall St. Rank hold IBB as of Q1 2022.

Advisory Alpha reported no remaining iShares Biotechnology ETF position as of Q1 2022 after selling out during the quarter.
Advisory Alpha sold 3,755 iShares Biotechnology ETF shares in Q1 2022, an estimated $573K.
Advisory Alpha first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 6 quarters.
Advisory Alpha's iShares Biotechnology ETF position peaked at $573K in Q4 2021.
897 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2022.

Based on Advisory Alpha's 13F filing for Q1 2022, filed 2 May 2022.